Lacosamide 50228-0193-60
- Manufacturer
- Sciegen Pharmaceuticals Inc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- March 18, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA205237
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 100 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
50228-0193-60Selected60 TABLET, FILM COATED in 1 BOTTLE (50228-193-60)
Other packages for this product(2)
1000 TABLET, FILM COATED in 1 BOTTLE (50228-193-10)
30 TABLET, FILM COATED in 1 BOTTLE (50228-193-30)